Article Versions Notes

Tracey H, Bate ST, Ford S, Patel P, Bloomer J, Patel A, Taskar KS. Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling. Pharmaceutics. 2025; 17(4):531. https://doi.org/10.3390/pharmaceutics17040531

Tracey, Helen, Simon T. Bate, Susan Ford, Parul Patel, Jackie Bloomer, Aarti Patel, and Kunal S. Taskar. 2025. "Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling" Pharmaceutics 17, no. 4: 531. https://doi.org/10.3390/pharmaceutics17040531

Tracey, H., Bate, S. T., Ford, S., Patel, P., Bloomer, J., Patel, A., & Taskar, K. S. (2025). Matrix Approach Assessment of Cabotegravir Drug–Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling. Pharmaceutics, 17(4), 531. https://doi.org/10.3390/pharmaceutics17040531